Last reviewed · How we verify

S-ketamine & Ropivacaine

Tao Zhang · FDA-approved active Small molecule Quality 2/100

S-ketamine & Ropivacaine is a Small molecule drug developed by Tao Zhang. It is currently FDA-approved.

At a glance

Generic nameS-ketamine & Ropivacaine
SponsorTao Zhang
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about S-ketamine & Ropivacaine

What is S-ketamine & Ropivacaine?

S-ketamine & Ropivacaine is a Small molecule drug developed by Tao Zhang.

Who makes S-ketamine & Ropivacaine?

S-ketamine & Ropivacaine is developed and marketed by Tao Zhang (see full Tao Zhang pipeline at /company/tao-zhang).

What development phase is S-ketamine & Ropivacaine in?

S-ketamine & Ropivacaine is FDA-approved (marketed).

Related